Jb. Anderson et al., The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk, EUR UROL, 39(4), 2001, pp. 390-398
Background: Benign prostatic hyperplasia (BPH) is often associated with enl
argement of the prostate gland, lower urinary tract symptoms, decreased uri
nary flow and a reduced quality of life. Furthermore, if the symptoms assoc
iated with BPH are left untreated, serious complications, such as acute uri
nary retention, may ensue. Evidence is emerging from long-term clinical stu
dies to suggest that BPH is a progressive disease, with some patients progr
essing much more rapidly than others.
Objective: This article aims to explore the natural history of BPH progress
ion from a molecular, pathological and clinical perspective, with emphasis
on the key clinical evidence to support the progressive nature of this dise
ase. How our increased understanding of the disease and of the risk factors
for BPH progression might be applied to improve current management practic
es are also discussed.
Conclusion: Strategies to identify patients most at risk and guidelines dir
ected towards longterm management, in addition to short-term treatment, may
be useful in helping to prevent BPH progression. Copyright (C) 2007 S. Kar
ger AG. Basel.